Comparison of a UL111a real-time PCR and pp65 antigenemia for the detection of cytomegalovirus

Journal of Medical Virology

Volumn 83, Issue 12, 2011, Pages 2143-2150

  Beckmann, Christiane ^a   Dumoulin, Alexis ^a   Rinaldo, Christine Hanssen ^b   Hirsch, Hans H ^a,c  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Antigenemia; Bland Altman plot; Cytomegalovirus; Probit analysis; Viral load

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; UL111A PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; ANTIGEN PRESENTING CELL; ARTICLE; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS; EXON; FEMALE; FOLLOW UP; GENE DOSAGE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; VIRUS DETECTION; VIRUS LOAD; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, VIRAL; CHILD; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHOPROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIROLOGY; YOUNG ADULT;

CYTOMEGALOVIRUS;

EID: 80054848480     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22232     Document Type: Article

References (28)

1. Bland JM, Altman DG. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310.
2. Boeckh M, Boivin G. 1998. Quantitation of cytomegalovirus: Methodologic aspects and clinical applications. Clin Microbiol Rev 11: 533-554.
3. Boeckh M, Huang M, Ferrenberg J, Stevens-Ayers T, Stensland L, Nichols WG, Corey L. 2004. Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR. J Clin Microbiol 42: 1142-1148.
4. Bordils A, Plumed JS, Ramos D, Beneyto I, Mascaros V, Molina JM, Cordoba J, Garcia J, Cruz JM. 2005. Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients. Transplant Proc 37: 3756-3759.
5. Dickenmann MJ, Cathomas G, Steiger J, Mihatsch MJ, Thiel G, Tamm M. 2001. Cytomegalovirus infection and graft rejection in renal transplantation. Transplantation 71: 764-767.
6. Egli A, Binet I, Binggeli S, Jaeger C, Dumoulin A, Schaub S, Steiger J, Sester U, Sester M, Hirsch HH. 2008. Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients. J Transl Med 6: 29-40.
7. Funk GF, Gosert R, Hirsch HH. 2007. Viral dynamics in transplant patients: Implication for disease. Lancet Infect Dis 7: 460-472.
8. Gault E, Michel Y, Dehee A, Belabani C, Nicolas JC, Garbarg-Chenon A. 2001. Quantification of human cytomegalovirus DNA by real-time PCR. J Clin Microbiol 39: 772-775.
9. Gerna G, Lilleri D, Baldanti F, Torsellini M, Giorgiani G, Zecca M, De Stefano P, Middeldorp J, Locatelli F, Revello MG. 2003. Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: A prospective, randomized, open-label trial. Blood 101: 5053-5060.
10. Gouarin S, Vabret A, Scieux C, Agbalika F, Cherot J, Mengelle C, Deback C, Petitjean J, Dina J, Freymuth F. 2007. Multicentric evaluation of a new commercial cytomegalovirus real-time PCR quantitation assay. J Virol Methods 146: 147-154.
11. Griscelli F, Barrois M, Chauvin S, Lastere S, Bellet D, Bourhis JH. 2001. Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. J Clin Microbiol 39: 4362-4369.
12. Helantera I, Egli A, Koskinen P, Lautenschlager I, Hirsch HH. 2010. Viral impact on long-term kidney graft function. Infect Dis Clin North Am 24: 339-371.
13. Hernando S, Folgueira L, Lumbreras C, San Juan R, Maldonado S, Prieto C, Babiano MJ, Delgado J, Andres A, Moreno E, Aguado JM, Otero JR. 2005. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients. Transplant Proc 37: 4094-4096.
14. Kalpoe JS, Kroes AC, de Jong MD, Schinkel J, de Brouwer CS, Beersma MF, Claas EC. 2004. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection. J Clin Microbiol 42: 1498-1504.
15. Kalpoe JS, van der Heiden PL, Barge RM, Houtzager S, Lankester AC, van Tol MJ, Kroes AC. 2007. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning. Eur J Haematol 78: 314-321.
16. Kotton CN. 2010. Management of cytomegalovirus infection in solid organ transplantation. Nat Rev Nephrol 6: 711-721.
17. Leruez-Ville M, Ouachee M, Delarue R, Sauget AS, Blanche S, Buzyn A, Rouzioux C. 2003. Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma. J Clin Microbiol 41: 2040-2046.
18. Li H, Dummer JS, Estes WR, Meng S, Wright PF, Tang YW. 2003. Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol 41: 187-191.
19. Machida U, Kami M, Fukui T, Kazuyama Y, Kinoshita M, Tanaka Y, Kanda Y, Ogawa S, Honda H, Chiba S, Mitani K, Muto Y, Osumi K, Kimura S, Hirai H. 2000. Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation. J Clin Microbiol 38: 2536-2542.
20. Piiparinen H, Hockerstedt K, Gronhagen-Riska C, Lappalainen M, Suni J, Lautenschlager I. 2001. Comparison of plasma polymerase chain reaction and pp65-antigenemia assay in the quantification of cytomegalovirus in liver and kidney transplant patients. J Clin Virol 22: 111-116.
21. Razonable RR, Eid AJ. 2009. Viral infections in transplant recipients. Minerva Med 100: 479-501.
22. Razonable RR, Brown RA, Wilson J, Groettum C, Kremers W, Espy M, Smith TF, Paya CV. 2002a. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation 73: 968-973.
23. Razonable RR, Paya CV, Smith TF. 2002b. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients. J Clin Microbiol 40: 746-752.
24. Sanghavi SK, Abu-Elmagd K, Keightley MC, St George K, Lewandowski K, Boes SS, Bullotta A, Dare R, Lassak M, Husain S, Kwak EJ, Paterson DL, Rinaldo CR. 2008. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients. J Clin Virol 42: 335-342.
25. Schroeder R, Michelon T, Fagundes I, Bortolotto A, Lammerhirt E, Oliveira J, Santos A, Bittar A, Keitel E, Garcia V, Neumann J, Saitovitch D. 2004. Cytomegalovirus disease latent and active infection rates during the first trimester after kidney transplantation. Transplant Proc 36: 896-898.
26. Sinclair J, Sissons P. 2006. Latency and reactivation of human cytomegalovirus. J Gen Virol 87: 1763-1779.
27. The TH, van der Bij W, van den Berg AP, van der Giessen M, Weits J, Sprenger HG, van Son WJ. 1990. Cytomegalovirus antigenemia. Rev Infect Dis 12: S734-S744.
28. Yakushiji K, Gondo H, Kamezaki K, Shigematsu K, Hayashi S, Kuroiwa M, Taniguchi S, Ohno Y, Takase K, Numata A, Aoki K, Kato K, Nagafuji K, Shimoda K, Okamura T, Kinukawa N, Kasuga N, Sata M, Harada M. 2002. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: Comparison of an antigenemia assay and quantitative real-time polymerase chain reaction. Bone Marrow Transplant 29: 599-606.